Fig. 1From: Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patientsSteroid-sparing effect of use of anti-TNF therapy. Dose of prednisolone (mg/day) at anti-TNF start and 12 months of anti-TNF treatment. n = 43 patients (number of patients with complete data available)Back to article page